Around eight types of new drugs developed in Taiwan will be approved by the U.S. Food and Drug Administration in two or three years, surpassing South Korea and Singapore, Legislative Speaker Wang Jin-pyng said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
U.S. spring wheat shipment rejected due to toxin contamination: TFDA
10/14/2025 01:52 PM - Business
Taiwan shares close down 0.48%
10/14/2025 01:48 PM - Politics
10 allies, U.S. advocate for Taiwan's participation in ICAO
10/14/2025 11:19 AM - Business
U.S. dollar down in Taipei trading
10/14/2025 10:15 AM - Business
Taiwan shares open higher
10/14/2025 09:08 AM